Health In Tech, Inc.
Calidad de datos: 100%
HIT
Nasdaq
Financial Services
Insurance Agents & Brokers
$1.42
▲
$0.06
(4.41%)
Cap. Mercado: 93.09 M
Precio
$1.42
Cap. Mercado
93.09 M
Rango del Día
$1.35 — $1.44
Rango de 52 Semanas
$0.55 — $4.02
Volumen
42,077
Apertura $1.35
Promedio 50D / 200D
$1.43
0.38% below
Promedio 50D / 200D
$1.96
27.52% below
Quick Summary
Puntos Clave
Earnings grew 90.74% over the past year
Generating 3.13 M in free cash flow
P/E of 72.79 — premium valuation
Cash machine — converts 245.05% of earnings into free cash flow
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)70.99%
Earnings (1Y)90.74%
FCF Growth (3Y)N/A
Calidad
Return on Equity
7.62%
Below sector avg (9.24%)
ROICN/A
Net Margin3.84%
Op. MarginN/A
Seguridad
Debt / Equity
N/A
Current Ratio2.87
Interest CoverageN/A
Valoración
PE (TTM)
72.79
Above sector avg (11.15)
P/B Ratio5.43
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Financial Services (2150 pares)
Comparación con Pares
vs mediana del sector Financial Services (2150 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 72.8 | 11.2 |
| P/B | 5.4 | 1.2 |
| ROE % | 7.6 | 9.2 |
| Net Margin % | 3.8 | 9.4 |
| Rev Growth 5Y % | — | 5.8 |
| D/E | — | 0.5 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 70.99% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | 90.74% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 33.33 M | Net Income (TTM) | 1.28 M |
| ROE | 7.62% | ROA | 5.69% |
| Gross Margin | 62.82% | Operating Margin | N/A |
| Net Margin | 3.84% | Free Cash Flow (TTM) | 3.13 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.87 |
| Interest Coverage | N/A | Asset Turnover | 1.48 |
| Working Capital | 9.81 M | Tangible Book Value | 17.16 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 72.79 | Forward P/E | N/A |
| P/B Ratio | 5.43 | P/S Ratio | 2.79 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 3.37% | ||
| Market Cap | 93.09 M | Enterprise Value | 85.07 M |
| Per Share | |||
| EPS (Diluted TTM) | 0.02 | Revenue / Share | 0.51 |
| FCF / Share | 0.05 | OCF / Share | 0.05 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 245.05% |
| SBC-Adj. FCF | 1.56 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | 33.33 M | 19.49 M |
| Net Income | 1.28 M | 670,477.0 |
| EPS (Diluted) | 0.02 | — |
| Gross Profit | 20.94 M | 15.44 M |
| Operating Income | — | — |
| EBITDA | — | — |
| R&D Expenses | 1.57 M | 2.81 M |
| SG&A Expenses | — | — |
| D&A | 900,577.0 | 541,141.0 |
| Interest Expense | 495,000.0 | 495,000.0 |
| Income Tax | 395,330.0 | 218,523.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 23.09 M | 15.77 M |
| Total Liabilities | 5.98 M | 2.60 M |
| Shareholders' Equity | 17.11 M | 13.17 M |
| Total Debt | — | — |
| Cash & Equivalents | 7.67 M | 7.85 M |
| Current Assets | 16.16 M | 10.78 M |
| Current Liabilities | 5.16 M | 2.13 M |
{"event":"ticker_viewed","properties":{"ticker":"HIT","listing_kind":"stock","pathname":"/stocks/hit","exchange":"Nasdaq","country":"US"}}